How is active monitoring in tx of prostate cancer?

The indication for active surveillance is therefore a clinically localized prostate cancer with a low risk of progression for patients whose life expectancy is greater than 10 years. And for : - Patients in the low risk group Amico (PSA <10 ng / mL and Gleason ≤ 6 and T1c or T2a). - 1 to 2 biopsy cores positive on at least 10 samples. - Tumor length <3 mm in total on the sample.